Hennion & Walsh Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.91M	Buy
2023 Q4	–	Sell
2023 Q3	$508K	Sell
2023 Q2	$840K	Buy
2023 Q1	$414K	Sell
2022 Q4	$667K	Buy
2022 Q3	$606K	Sell
2022 Q2	$477K	Buy
2022 Q1	$695K	Buy
2021 Q4	$608K	Buy